Oral GLP-1s Without Fasting or Reduced Efficacy
New oral drug delivery approach protects peptide-based drugs like GLP-1s from destruction in the stomach.
Whether it’s developing new technologies or pioneering new areas, Duke Biomedical Engineering is a leading force driving the discoveries and innovations that help clinicians save lives.
From harnessing supercomputers to create patient-specific digital twins to engineering the microbial communities we interact with every day, Duke Engineering is home to interdisciplinary centers poised to make real-world impacts.
Leaders in developing and applying genomic technologies
Multidisciplinary research in tissue, cellular, and protein engineering.
Improving women’s cancer diagnosis, prevention, and treatment worldwide.
Training commercial, technical, and academic leaders of next-generation broadband technologies.
Research excellence and scholarship at the nexus of quantitative biology, synthetic biology, and machine learning.
Harnessing wearable sensors, high performance computing, and extended reality to find, track, and treat health conditiosn in real-time.
New oral drug delivery approach protects peptide-based drugs like GLP-1s from destruction in the stomach.
May 25
May 28
Join researchers, clinicians, innovators, and students for a dynamic symposium exploring the future of neural engineering and neurotechnology, and engage with cutting-edge ideas, interdisciplinary collaboration, and real-world applications shaping the […]
Trent Semans Center for Health Education
Jun 10
Last day to withdraw with W from Term 1 classes (undergraduates only)